Form4insider filings, from the source

SEC Form 4 · accession 0000932440-16-000415

EAGLE PHARMACEUTICALS, INC. · EGRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jay Moorin
10% Owner
Period of report
Jun 23, 2016
Accepted (ET)
Jun 30, 2016 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827871

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock $0,001 par valueF3,F2Jun 23, 2016J9,903—D5,582IBy ProQuest Financial LLC
Common Stock, $0.001 par valueF1holding———4,770,828IBy ProQuest Investments IV, L.P.

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses